Home Cart Sign in  
Chemical Structure| 101246-66-6 Chemical Structure| 101246-66-6

Structure of Phenserine
CAS No.: 101246-66-6

Chemical Structure| 101246-66-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Phenserine is a physostigmine analog that inhibits acetylcholinesterase.

Synonyms: (-)-Eseroline phenylcarbamate; (-)-N-Phenylcarbamoyleseroline; (-)-Phenserine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Phenserine

CAS No. :101246-66-6
Formula : C20H23N3O2
M.W : 337.42
SMILES Code : CN1[C@](N(C)CC2)([H])[C@]2(C)C3=C1C=CC(OC(NC4=CC=CC=C4)=O)=C3
Synonyms :
(-)-Eseroline phenylcarbamate; (-)-N-Phenylcarbamoyleseroline; (-)-Phenserine
MDL No. :MFCD00672748

Safety of Phenserine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02925650 Alzheimer's Disease Phase 1 Phase 2 Recruiting December 31, 2019 United States, California ... More >> UCSD Alzheimer's Disease Research Center Recruiting La Jolla, California, United States, 92037 Contact: Daniel Szpak, RN    858-249-0558    dszpak@ucsd.edu    United States, Indiana IU Health Partners, Adult Neurology Clinic Recruiting Indianapolis, Indiana, United States, 46202 Contact: Stephanie Fritz, RN, BSN    317-274-4363    safritz@iu.edu    United States, Maryland Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21287 Contact: Jackie Darrow    410-550-8708    jdarrow2@jhmi.edu    United States, Missouri Washington University Sleep Medicine Center Recruiting Brentwood, Missouri, United States, 63144 Contact: Jill Boyd    314-747-3477    massenaj@wustl.edu Less <<
NCT01072812 Alzheimer's Disease ... More >> Amnestic Mild Cognitive Impairment Less << Phase 1 Terminated(Business decision b... More >>ased on funding) Less << - United States, Texas ... More >> CEDRA Clinical Research, LLC San Antonio, Texas, United States, 78217 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.96mL

0.59mL

0.30mL

14.82mL

2.96mL

1.48mL

29.64mL

5.93mL

2.96mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories